Our signature programs & focus areas
A healthier world is attainable and achievable, but access remains unequal. At the BMS Foundation, our mission is to improve global health. We are developing grantee relationships in regions of the world that are underserved and heavily burdened through our signature programs in Brazil, India, ten countries in Sub-Saharan Africa, and across the United States.
Evolution of our impact
Relationships are at the core of what we do, enabling us to improve global health in ways that we could not accomplish alone. We strive to improve access to healthcare for underserved populations in the geographies where we are focused. That’s why we support multifaceted endeavors with organizations serving these communities who are developing innovative, sustainable solutions to improve global health.
To learn more about the grantmaking process, please contact us.
We are leveraging lessons from our decade of work addressing lung cancer disparities in the U.S. Through our Multinational Lung Cancer Control Program (MLCCP), we are building the capacity to better diagnose lung cancer, while we remain committed to addressing other high disease burden cancers prevalent in the countries where we are focused.
We have a steadfast commitment to be a leader in the wider pediatric community and improve global health for pediatric patients. Our work is aligned with innovative organizations, health systems and capacity-building initiatives focused on pediatric cancers, sickle cell disease and beta-thalassemia.
The Robert A. Winn Excellence in Clinical Trials Award Program addresses the priority of improving representation in clinical trials. By training the next generation of clinical trialists in the science of community engagement, we believe we can include more patients in clinical trials that match the epidemiology of the disease studied. Research areas include cancer, cardiovascular disease and neuropsychiatry.